Prevalence and predictors of Highly active antiretroviral therapy use in patients with HIV infection in the United States
Cunningham, W.E.; Markson, L.E.; Bozzette, S.A.; Shapiro, M.F.; Wenger, N.S.; Andersen, R.M.; Crystal, S.H.; Fleishman, J.A.; Golin, C.; Gifford, A.; Liu, H.H.; Nakazono, T.T.; Morton, S.; Hcsus, C.
Journal of Acquired Immune Deficiency Syndromes (1999) 25(2): 115-123
2000
ISSN/ISBN: 1525-4135 Accession: 077356602
PDF emailed within 1 workday: $29.90
Related References
Cunningham, W.E.; Markson, L.E.; Andersen, R.M.; Crystal, S.H.; Fleishman, J.A.; Golin, C.; Gifford, A.; Liu, H.H.; Nakazono, T.T.; Morton, S.; Bozzette, S.A.; Shapiro, M.F.; Wenger, N.S. 2000: Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States JAIDS Journal of Acquired Immune Deficiency Syndromes 25(2): 115-123&Na;, 2001: Prevalence and Predictors of Highly Active Antiretroviral Therapy use in Patients with HIV Infection in the United States Infectious Diseases in Clinical Practice 10(1): 70-71
Cunningham, W.E.; Markson, L.E.; Andersen, R.M.; Crystal, S.H.; Fleishman, J.A.; Golin, C.; Gifford, A.; Liu, H.H.; Nakazono, T.T.; Morton, S.; Bozzette, S.A.; Shapiro, M.F.; Wenger, N.S. 2000: Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization Journal of Acquired Immune Deficiency Syndromes 25(2): 115-123
Clough, L.A.; Haas, D.W.; Raffanti, S. 1997: Predictors and prevalence of incomplete virologic response to protease inhibitor-based highly active antiretroviral therapy for HIV infection Clinical Infectious Diseases 25(2): 397
Batterham, M.J.; Garsia, R.; Greenop, P. 2002: Prevalence and predictors of HIV-associated weight loss in the era of highly active antiretroviral therapy International Journal of Std and Aids 13(11): 744-747
Swanson, S.J.; Kirk, A.D.; Ko, C.W.; Jones, C.A.; Agodoa, L.Y.; Abbott, K.C. 2002: Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System Transplant Infectious Disease: An Official Journal of the Transplantation Society 4(3): 144-147
Reus, S.; Portilla, J.ín.; Gimeno, A.; Sánchez-Payá, J.é; García-Henarejos, J.A.; Martínez-Madrid, O.; Usó, J.; Roca, B.; Galindo, M.ía.J.é; López-Aldeguer, J.é 2004: Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy Enfermedades Infecciosas y Microbiologia Clinica 22(3): 142-149
Levine, R.S.; Briggs, N.C.; Kilbourne, B.S.; King, W.D.; Fry-Johnson, Y.; Baltrus, P.T.; Husaini, B.A.; Rust, G.S. 2007: Black-White mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996 American Journal of Public Health 97(10): 1884-1892
Levine, R.S.; Briggs, N.C.; Kilbourne, B.S.; King, W.D.; Fryjohnson, Y.; Baltrus, P.T.; Husaini, B.A.; Rust, G.S. 2007: Black-white mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996 American Journal of Public Health (1971) 97(10): 1884-1892
Bansil, P.; Jamieson, D.J.; Posner, S.F.; Kourtis, A.P. 2007: Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART) Journal of Women's Health 16(2): 159-162
Kaplan, J.E.; Hanson, D.; Dworkin, M.S.; Frederick, T.; Bertolli, J.; Lindegren, M.L.; Holmberg, S.; Jones, J.L. 2000: Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 30(Suppl 1): S5-14
Hutchinson, A.B.; Farnham, P.G.; Dean, H.D.; Ekwueme, D.U.; del Rio, C.; Kamimoto, L.; Kellerman, S.E. 2006: The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences Journal of Acquired Immune Deficiency Syndromes 43(4): 451-457
Hutchinson, A.B.; Farnham, P.G.; Dean, H.D.; Ekwueme, D.U.; Del Rio, C.; Kamimoto, L.; Kellerman, S.E. 2006: The economic burden of HIV in the united states in the era of highly active antiretroviral therapy : Evidence of continuing racial and ethnic differences Journal of Acquired Immune Deficiency Syndromes (1999) 43(4): 451-457
Lenjisa, J.L.; Wega, S.S.; Lema, T.B.; Ayana, G.A. 2015: Outcomes of highly active antiretroviral therapy and its predictors: a cohort study focusing on tuberculosis co-infection in South West Ethiopia Bmc Research Notes 8: 446
Zaragoza-Macias, E.; Cosco, D.; Nguyen, M.L.; Del Rio, C.; Lennox, J. 2010: Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population Aids Research and Human Retroviruses 26(2): 133-138
Fife, K.H.; Wu, J.W.; Squires, K.E.; Watts, D.H.; Andersen, J.W.; Brown, D.R. 2009: Prevalence and Persistence of Cervical Human Papillomavirus Infection in HIV-Positive Women Initiating Highly Active Antiretroviral Therapy Journal of Acquired Immune Deficiency Syndromes (1999) 51(3): 274-282
Fife, K.H.; Wu, J.W.; Squires, K.E.; Watts, D.H.; Andersen, J.W.; Brown, D.R. 2009: Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 51(3): 274-282
Johnston, J.; King, C.M.; Shanks, S.; Khademi, S.; Nelson, J.; Yu, J.; Barbosa, P. 2011: Prevalence of plantar verrucae in patients with human immunodeficiency virus infection during the post-highly active antiretroviral therapy era Journal of the American Podiatric Medical Association 101(1): 35-40
Patassi, A.; Benaboud, S.; Landoh, D.E.; Salou, M.; Dagnra, A.C.; Saka, B.; Krivine, A.; Meritet, J.-F.ço.; Pitché, P.; Salmon-Ceron, D. 2016: Hepatitis B infection in HIV-1-infected patients receiving highly active antiretroviral therapy in Lomé, Togo: Prevalence and molecular consequences South African Medical Journal 106(6)
Rietschel, P.; Corcoran, C.; Stanley, T.; Basgoz, N.; Klibanski, A.; Grinspoon, S. 2000: Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 31(5): 1240-1244